Developing an effective treatment for COPD, and especially pulmonary emphysema, will require an understanding of how fundamental changes at the molecular level affect the macroscopic structure of the lung. Currently, there is no accepted model that encompasses the biochemical and mechanical processes responsible for pulmonary airspace enlargement. We propose that pulmonary emphysematous changes may be more accurately described as an emergent phenomenon, involving alterations at the molecular level that eventually reach a critical structural threshold where uneven mechanical forces produce alveolar wall rupture, accompanied by advanced clinical signs of COPD. The coupling of emergent morphologic changes with biomarkers to detect the process, and counteract it therapeutically, represents a practical approach to the disease.
The concept of disease as an emergent phenomenon has gained increasing acceptance with the recognition that physiological disorders result from a convergence of abnormalities at the molecular level. 1, 2 With regard to the lung, computer simulations of pulmonary emphysema have shown that disturbances at the local tissue level can lead to global structural and mechanical alterations, represented by widespread distention and rupture of alveolar walls. 3, 4 In one study, a network of springs (representing elastic fibers and collagen) was modified by either increasing their stiffness or removing them entirely, resulting in architectural changes similar to those seen in pulmonary fibrosis and emphysema, respectively. 5 The changes in the network did not produce significant deformations until a critical threshold was reached, suggesting that it may be possible to predict the development of lung disease by identifying early changes at the molecular and microscopic levels.
The principle of emergence arose from the realization that physical phenomena cannot be understood by merely identifying their individual parts. 6 Instead, interactions among these components can produce unexpected behavior that cannot be predicted on the basis of their individual properties. Chemical reactions reflect this process, where the recombination of elements to form new products may involve the interaction of indeterminate factors related to concentration, temperature, and time. However, this concept was only applied to the lung when Macklem suggested that pulmonary disease cannot be understood by studying individual molecules in isolation.
One of the best examples of emergent phenomena involves viral or bacterial epidemics, which usually advance outward from a single location. In this situation, the movement of the disease vector depends on a variety of circumstances such as population density and mobility. 8, 9 Consequently, the epidemic may behave in a nonlinear fashion, and the incidence of infection remains uncertain until it involves a relatively large population.
This pattern of emergence may also be applicable to pulmonary emphysema, in which local changes in alveolar architecture spread to encompass large areas of the lung. As with infection, a number of interconnected factors regulate the transition from normal to distended and ruptured airspaces. Although there are inflammatory events associated with this process, they may be variable in nature and not sufficient by themselves to cause distention and rupture of alveolar walls; rather, the uneven mechanical forces in the lung interstitium are directly responsible for airspace enlargement. The propagation of abnormal mechanical stress is governed by various competing factors, such as elastase activity, antiprotease levels, and rates of tissue repair. 10, 11 Their interactions at the molecular level determine the rate of progression of disease. This process would encompass both centrilobular emphysema, which expands outward from the central airways, and panacinar pulmonary emphysema, which spreads more evenly through the lung, but may be less applicable to senile emphysema, in which airspace enlargement is more uniform and does not involve rupture of alveolar walls. 12 Elastic Fiber Injury as a Measure of Pulmonary Microarchitectural Changes
The structural integrity of the lung depends on various components of the extracellular matrix, including collagen, elastin, and proteoglycans. Changes in the distribution of these constituents or their inherent mechanical properties in response to injury can alter the transmission of forces through the lung interstitium, resulting in disruption of alveolar architecture. 13, 14 As this process progresses, it adversely affects the movement of air within the lung, which diminishes gas exchange and may eventually cause respiratory failure.
In pulmonary emphysema, damage to the elastic fibers within alveolar walls impairs the mechanical recoil associated with exhalation, thereby increasing the residual volume of air in the lung. 15 The elevated pressure within the alveoli eventually causes dilatation and rupture of their walls, resulting in decreased lung surface area and reduced gas exchange. The destruction of the elastic fiber network may initially involve only scattered foci within the lung parenchyma, causing only minimal architectural changes. However, as injury to these fibers progresses, increasingly uneven transmission of forces through the lung exerts greater pressure on the alveolar walls, resulting in more widespread airspace enlargement and rupture.
The mechanical properties of elastic fibers are derived from the specialized features of the core elastin protein, which contains distensible, coiled peptides that store the energy needed to expel air from the lungs. 16 The elastin cross-links, desmosine and isodesmosine (DID), provide structural support for the fibers and play an important role in determining the mechanical and morphologic features of the lung parenchyma (Fig 1) . 17 This scenario was dramatically illustrated in a study involving inhibition of cross-link formation in a model of cadmium chloride-induced lung injury. Whereas untreated animals developed marked interstitial fibrosis, those given a cross-link inhibitor, betaaminopropionitrile, exhibited prominent pulmonary emphysema. 18 Due to its unique presence in elastin, DID may serve as a biomarker for lung microarchitectural changes associated with pulmonary emphysema. A number of studies indicate that increased levels of DID in sputum, blood, or urine are associated with COPD, and with pulmonary emphysema in particular. [19] [20] [21] [22] [23] chestjournal.org loss of lung mass in patients with COPD, as measured by high-resolution CT imaging. 24 
Modeling the Relationship Between Elastic Fiber Injury and Altered Lung Morphology
The loss of elastin cross-links and subsequent mechanical disruption of alveolar walls may be modeled with the use of percolation networks, which provide a powerful tool for investigating the emergence of complex phenomena. Such networks are based on the random movement of fluids through a matrix of interconnecting bonds, in which the convergence of isolated currents produces repeating patterns of behavior over a wide range of scales. The self-similar nature of these networks is useful for studying potential relationships between macroscopic and molecular processes.
With regard to the lung, damage to elastic fibers can be modeled by incorporating a percolation system composed of interconnecting units with two different levels of stiffness, corresponding to either structurally weak or strong elastic fibers, respectively. 25 Such networks are commonly used to map the effects of forces within structural materials, and their application to the lung extracellular matrix may provide a theoretical framework for studying the emergence of emphysematous changes.
The two types of structural units are arranged randomly throughout a three-dimensional lattice, simulating diffuse elastic fiber damage. The amount of mechanical deflection in response to a force is inversely proportional to their stiffness, with the weaker elements being more prone to stretching. Under these conditions, the percolation of mechanical forces through the lattice depends on the ratio of the two components. When the proportion of weak units is low, mechanical forces are largely transmitted through their stiffer counterparts, ensuring that there is little or no disruption of lung architecture. Conversely, when weak units predominate, mechanical forces mainly percolate along less robust pathways, producing distortion of lung architecture.
The ratio of the two components is therefore the primary determinant in modeling the emergence of pulmonary emphysema. At a critical point, the disease would shift from a latent to an active state, characterized by changes in FEV 1 and other parameters. The selfsimilar nature of percolation systems further suggests that the ratio may reflect analogous patterns of injury at different levels of scale, ranging from disconnected elastin cross-links to ruptured alveolar walls and visibly enlarged airspaces (Fig 2) . The interconnectedness of these multilevel changes may explain why attenuating inflammation alone does not stop the progression of the disease.
The Relationship Between Elastic Fibers and Hyaluronan
The maintenance of elastic fiber integrity may depend on its interaction with other components of the extracellular matrix. With regard to this possibility, our laboratory has previously shown that pretreatment of the lung with a nonelastolytic enzyme, hyaluronidase, enhances airspace enlargement in a model of pulmonary emphysema induced by intratracheal instillation of elastase. 26 Degradation of hyaluronan (HA) may facilitate the breakdown of elastic fibers by making them more susceptible to injury. This hypothesis is supported by additional studies indicating that treatment with an aerosol preparation of HA prevented airspace enlargement in both the elastase and cigarette smoke models of pulmonary emphysema. The attachment of the nebulized HA to lung elastic fibers suggests that it acts as a physical barrier to elastases and other elastolytic agents, and may likewise prevent possible proinflammatory elastin fragments from inducing further injury. [27] [28] [29] [30] Such protection may also occur naturally, due to the close anatomic association between endogenous HA and elastic fibers.
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The unique hydrophilic properties of HA may also improve the mechanical characteristics of elastic fibers, which require absorption of water onto the hydrophobic domains of elastin for the storage of elastic energy. 32, 33 Evidence supporting this hypothesis was provided by a study which showed that HA and other proteoglycans stabilize alveolar walls by reducing the uneven distribution of forces in the extracellular matrix. 34 Whether a loss of HA in the extracellular matrix might enhance the progression of human pulmonary emphysema remains to be determined. However, lung HA content is significantly decreased in patients with COPD, including those with alpha 1 -antiprotease deficiency, in which HA content correlates with a decline in FEV 1 , diffusing capacity of the lungs for carbon monoxide, and serum levels of the antiprotease. [35] [36] [37] Therapeutic Strategies to Prevent the Emergence of Pulmonary Emphysema
Given the potential importance of emergent phenomena in pulmonary emphysema, the most effective approaches to treatment might involve interventions directed at the mechanisms responsible for propagation of uneven mechanical forces in the lung. However, the multiplicity of factors involved in this process has prevented the development of a widely effective therapy. Aside from alpha 1 -antiprotease augmentation, which is limited to a small subgroup of patients with COPD, there is no commercially available agent that slows the progression of the disease. 38 The central role of elastic fiber damage in the development of alveolar wall stress suggests that treatments focused on protecting this matrix component from injury might have a greater likelihood of success. The challenge in developing such a therapy will be to design a compound that is effective against a wide variety of enzymes and other agents with elastolytic activity. To date, specific elastase inhibitors that were subjected to clinical trials have shown only limited efficacy. [39] [40] [41] Similarly, attempts to regenerate normal mechanical forces by restoration of elastic fibers or alveolar septa have not resulted in a clinically promising agent, although further development of stem cell therapies could make this approach more effective. 42 Our laboratory tested the use of nebulized HA as a prospective form of treatment for pulmonary emphysema. A 2-week, randomized, double-blind, placebo-controlled, Phase IIa safety trial was performed in patients with smoke-related COPD to evaluate the safety and efficacy of nebulized HA. 43 Inhalation of a 150-kDa aerosol preparation of HA, at a concentration of 0.03%, resulted in a significant decrease in plasma DID over a 3-week period following initiation of treatment, whereas levels in the placebo group remained unchanged. Sputum DID, a specific measure of lung elastin degradation, exhibited a more dramatic decrease over the same time interval in HA-treated patients, although this finding was limited by the fact that similar measurements were not performed in the placebo group. 
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Although a number of studies indicate proinflammatory events associated with low molecular weight HA (LMWHA), these findings are generally associated with preexisting acute lung injury and may not be representative of the chronic, subacute inflammatory process associated with COPD. 44, 45 Moreover, the current clinical trial showed no evidence of LMWHA-induced inflammation, and long-term treatment of smoke-exposed animals with aerosolized LMWHA did not increase the number of leukocytes in either BAL fluid or histologic sections of the lung. 46 Conclusions COPD may comprise a disparate group of lung injuries with variable clinical presentations and multiple pathogenic mechanisms such as excess elastase activity, oxidative stress, apoptosis, and autoimmunity. 11 Nevertheless, the interaction of these various processes in the lung parenchyma may lead to similar patterns of injury at different levels of scale, including loss of elastin cross-links, microscopic fragmentation of elastic fibers, and macroscopic rupture of alveolar walls. Consequently, structural components such as DID may be better biomarkers of pulmonary emphysema than inflammatory mediators because they reflect the dynamics of percolating forces within the lung. 47, 48 As shown by the clinical trial involving HA, measurement of elastin cross-links may offer a more rapid means of determining efficacy, thereby encouraging increased testing of potential treatments for the disease.
